Yang H - Search Results

1

Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal Pneumonia.

Jing S, Kong X, Wang L, Wang H, Feng J, Wei L, Meng Y, Liu C, Chang X, Qu Y, Guan J, Yang H, Zhang C, Zhao Y, Song W. Jing S, et al. Among authors: yang h. Microbiol Spectr. 2022 Apr 27;10(2):e0234021. doi: 10.1128/spectrum.02340-21. Epub 2022 Mar 23. Microbiol Spectr. 2022. PMID: 35319277 Free PMC article.

2

Improved Antiviral Activity of Classical Swine Fever Virus-Targeted siRNA by Tetrahedral Framework Nucleic Acid-Enhanced Delivery.

Dong H, Song G, Ma D, Wang T, Jing S, Yang H, Tao Y, Tang Y, Shi Y, Dai Z, Zhu JM, Liu T, Wang B, Leng X, Shen X, Zhu C, Zhao Y. Dong H, et al. Among authors: yang h. ACS Appl Mater Interfaces. 2021 Jun 30;13(25):29416-29423. doi: 10.1021/acsami.1c08143. Epub 2021 Jun 20. ACS Appl Mater Interfaces. 2021. PMID: 34148345

3

Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers.

Cui Y, Cui D, Ren X, Chen X, Liu G, Liu Z, Wang Y, Qu X, Zhao Y, Yang H. Cui Y, et al. Among authors: yang h. Front Pharmacol. 2021 Jun 2;12:660541. doi: 10.3389/fphar.2021.660541. eCollection 2021. Front Pharmacol. 2021. PMID: 34149414 Free PMC article.

4

Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection.

Feng J, Sun D, Wang L, Li X, Guan J, Wei L, Yue D, Wang X, Zhao Y, Yang H, Song W, Wang B. Feng J, et al. Among authors: yang h. World J Microbiol Biotechnol. 2021 Nov 27;38(1):6. doi: 10.1007/s11274-021-03182-4. World J Microbiol Biotechnol. 2021. PMID: 34837116

5

Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta^® in Healthy Chinese Male Volunteers.

Cui Y, Cui D, Ren X, Chen X, Liu G, Liu Z, Wang Y, Qu X, Zhao Y, Yang H. Cui Y, et al. Among authors: yang h. Front Pharmacol. 2022 May 4;13:907413. doi: 10.3389/fphar.2022.907413. eCollection 2022. Front Pharmacol. 2022. PMID: 35600852 Free PMC article.

6

A randomized, single-blind, single-dose, parallel-group study in healthy subjects to demonstrate the pharmacokinetic equivalence of trastuzumab and its biosimilar.

Wang Y, Liu Z, Deng Q, Su Z, Xue J, Zhao Y, Yang H. Wang Y, et al. Among authors: yang h. Expert Opin Drug Metab Toxicol. 2023 Jul-Dec;19(11):849-855. doi: 10.1080/17425255.2023.2243823. Epub 2023 Aug 3. Expert Opin Drug Metab Toxicol. 2023. PMID: 37526387 Clinical Trial.

7

Pharmacokinetics and bioequivalence of sunitinib and Sutent^® in Chinese healthy subjects: an open-label, randomized, crossover study.

Wang Y, Deng Q, Gao Z, Liu G, Su Z, Zhao Y, Zhang L, Yang H. Wang Y, et al. Among authors: yang h. Front Pharmacol. 2023 Nov 10;14:1294688. doi: 10.3389/fphar.2023.1294688. eCollection 2023. Front Pharmacol. 2023. PMID: 38026975 Free PMC article.

8

A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects.

Xu Z, Wang Y, Liu G, Chen J, Wang W, Cheng Y, Ren Q, Cui Y, Yang W, Liu Z, Chen X, Xue J, Chang T, Qu X, Yu S, Zhou Y, Xu K, Su Z, Deng Q, Zhao Y, Yang H. Xu Z, et al. Among authors: yang w, yang h. Expert Opin Investig Drugs. 2022 Jul;31(7):737-746. doi: 10.1080/13543784.2022.2067528. Epub 2022 Apr 19. Expert Opin Investig Drugs. 2022. PMID: 35427205 Clinical Trial.

9

A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects.

Xu Z, Wang Y, Liu Z, Zhang R, Zhou Y, Yu J, Lan J, Liang W, Liu G, Qu X, Chen J, Su Z, Yu S, Cheng Y, Wang W, Ren Q, Deng Q, Zhao Y, Yang H. Xu Z, et al. Among authors: yang h. Int Immunopharmacol. 2022 Aug;109:108780. doi: 10.1016/j.intimp.2022.108780. Epub 2022 Apr 20. Int Immunopharmacol. 2022. PMID: 35461158 Clinical Trial.

10

A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif^® in healthy Chinese subjects.

Liu G, Xue J, Wang Y, Liu Z, Li X, Qu D, Su Z, Xu K, Qu X, Qu Z, Sun L, Cao M, Wang Y, Chen X, Yu J, Liu L, Deng Q, Zhao Y, Zhang L, Yang H. Liu G, et al. Among authors: yang h. J Cancer Res Clin Oncol. 2023 Jun;149(6):2585-2593. doi: 10.1007/s00432-022-04148-1. Epub 2022 Jun 30. J Cancer Res Clin Oncol. 2023. PMID: 35771264 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,640 results

Search Page

Filters